Nektar Therapeutics (NKTR)
(Delayed Data from NSDQ)
$1.30 USD
+0.03 (2.36%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.30 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.23 | -4.35% |
Earnings Summary
For their last quarter, Nektar Therapeutics (NKTR) reported earnings of -$0.25 per share, missing the Zacks Consensus Estimate of -$0.21 per share. This reflects a negative earnings surprise of 19.05%. Look out for NKTR's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.23 per share, reflecting a year-over-year decrease of 21.05%.
Earnings History
Price & Consensus
Zacks News for NKTR
What Makes Nektar (NKTR) a New Buy Stock
NKTR: What are Zacks experts saying now?
Zacks Private Portfolio Services